Innovations
Treatments
VisCardia Advances Breakthrough Heart Failure Therapy Trial with First US Implant
VisCardia begins RECOVER-HF trial to evaluate its VisONE Synchronized Diaphragmatic Stimulation Therapy in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).

